Extrawell Pharmaceutical Holdings Limited (0858.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 107.55M |
| Enterprise Value | 170.72M |
| P/E Ratio | -0.53 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 3.23 |
| Price/Book Ratio | 0.19 |
| Enterprise/Revenue | 3.97 |
| Enterprise/EBITDA | 1.51 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -6.42 |
| Operating Margin | -0.22 |
| Return On Assets | -0.31 |
| Return On Equity | -0.3 |
| Revenue | 55.43M |
| Revenue/Share | 0.02 |
| Gross Profit | 21.87M |
| EBITDA | 255.11M |
| Net Income | 222.64M |
| Diluted EPS | 0.07 |
| Total Cash | 115.06M |
| Total Cash/Share | 0.05 |
| Total Debt | 152.68M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 13.06 |
| Book Value Per Share | 0.37 |
| 52-Week Change | 39.22 |
| 52-Week High | 0.15 |
| 52-Week Low | 0.05 |
| Moving Average 50 Days | 0.07 |
| Moving Average 200 Days | 0.09 |
| Average Volume | 1.32M |
| Shares Outstanding | 2.39B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |